The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketin
Brazilian President Luiz Inacio Lula da Silva praised the Brazil-India partnership as one of equals, highlighting shared priorities and growing trade. He expressed confidence that bilateral trade could exceed targets. India and Brazil also strengthened cooperation in pharmaceutical and medic
India and Brazil exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the field of regulation of pharmaceutical and medical products.
Apart from the increased allocation, the central drug regulator has been strenghtened, a plan for building over 1,000 medical trial sites has been announced, and cancer medicines have been exempted from custom duties.
Central Drugs Laboratories have identified 74 drug samples, and State Drugs Testing Laboratories have identified 93 drug samples as Not of Standard Quality (NSQ) for the month of December 2025, a press note said.
Chandrapur (Maharashtra) [India], December 24: Aansh Hospital & IVF Center, often cited as one of the best IVF centers in Chandrapur, has set a new benchmark for reproductive medicine in the Vidarbha region by partnering with Garbha.ai. This collaboration makes Aansh the first center in Maha
The Central Drugs Standard Control Organisation (CDSCO) on Friday released the list of Not of Standard Quality (NSQ) and Spurious drugs for November 2025 on its portal, according to a release.
New Delhi [India], December 10: Lords Mark Industries Ltd. (LMIL) has achieved a defining milestone in India's med-tech landscape by receiving the licence to manufacture Class C World's First AI-Based Smart HemodialysisMachines from the Central Drugs Standard Control Organisation (CDSCO), a
Mumbai (Maharashtra) [India], November 12: Lupin Digital Health, India's leading cardiac digital-therapeutics company, today announced the launch of VITALYFE™, an AI-powered cardiometabolic wellness platform designed to help India's working professionals reclaim their heart health. Built on
A new law is being proposed to grant statutory powers to the Central Drugs Standard Control Organisation (CDSCO) to regulate the manufacture, distribution, and sale of drugs, medical devices, and cosmetics.
Bangalore (Karnataka) [India], October 14: Reghelps SRC, a newly established Contract Research Organization (CRO) in India, announced the launch of its comprehensive clinical research services for global Medical Device and In-Vitro Diagnostic Device (IVD) manufacturers.